Delivery Order SPE2DB24D2216-SPE2DB25FGNHJ

Award Date 4/7/25
Potential Completion Date 4/28/25
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,580.76, is for the delivery of PREVYMIS 480 MG TABLET 7S, a pharmaceutical product. The contract is a firm-fixed price delivery order with an ultimate completion date of January 9, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,719.34 firm fixed-price delivery order is for the supply of PREVYMIS 480 MG TABLET 7S, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025 and was awarded on January 31, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,438.70 fixed-price delivery order is for the supply of PREVYMIS 480 MG TABLET 7S, a pharmaceutical product. The contract has an ultimate completion date of January 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,719.34 firm fixed price delivery order is for PREVYMIS 480 MG TABLET 7S, a pharmaceutical product. The contract has an ultimate completion date of February 19, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,580.76 fixed-price delivery order covers the provision of PREVYMIS 480 MG TABLET 7S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for supplying...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,438.70, is for the delivery of PREVYMIS 480 MG TABLET 7S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $9,438.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PREVYMIS 480 MG TABLET 7S, a pharmaceutical product, and has an ultimate completion date of April 3, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award does not have a set-aside designation, indicating open competition....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order with a firm fixed price of $9,438.70 and a completion date of March 17, 2025. The contract, awarded by the Defense Logistics Agency (DLA), is for the supply of PREVYMIS 480 MG TABLET 7S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $4,719.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PREVYMIS 480 MG TABLET 7S, a pharmaceutical product, with a performance period through June 4, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves...
This is a federal delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $8,845.92 firm-fixed-price contract is for the supply of PREVYMIS 240 MG TABLET 7S, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables DLA to efficiently procure a comprehensive range of medical commodities from...
  • SPE2DB24D2216
    Indefinite Delivery Contract
  • SPE2DB24D2216-SPE2DB25FGNHJ
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,719.34, is for the delivery of PREVYMIS 480 MG TABLET 7S, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 7/7/25, 1:19 PM